AAP Experience 2014 continues to amaze!

Article

Days 1 and 2 at the American Academy of Pediatrics 2014 National Conference and Exhibition in San Diego, California, offered more of what’s new in pediatric research through symposiums, plenary sessions, poster presentations, and myriad educational sessions covering topics from the latest treatment guidelines to diagnosing clinical manifestations of disease to the newest therapies.

Days 1 and 2 at the American Academy of Pediatrics 2014 National Conference and Exhibition in San Diego, California, offered more of what’s new in pediatric research through symposiums, plenary sessions, poster presentations, and myriad educational sessions covering topics from the latest treatment guidelines to diagnosing clinical manifestations of disease to the newest therapies. Here are summaries of just a few of these sessions in case you missed them.

Recent Videos
Paul Kruszka, MD
Herbert Bravo, MD
Tina Tan, MD
Paul Kruszka, MD, MPH, FACMG
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP
H. Westley Phillips, MD
David Turkewitz, MD
H. Westley Phillips, MD
Related Content
Upadacitinib effective in treating atopic dermatitis through 76 weeksLatest revision | Image Credit: © Rochu_2008 - © Rochu_2008 - stock.adobe.com.

Upadacitinib effective in treating atopic dermatitis through 76 weeks

Joshua Fitch, Senior Editor
December 10th 2024
Article

In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
A preview of the November/December issue of Contemporary Pediatrics

A preview of the November/December issue of Contemporary Pediatrics

Tina Q Tan, MD, FAAP, FIDSA, FPIDS
December 10th 2024
Article

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the final Contemporary Pediatrics journal of the year.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Survey: trofinetide improves tolerability among Rett syndrome patients | Image Credit: © ARBA - © ARBA - stock.adobe.com.

Survey: titrating trofinetide improves tolerability among Rett syndrome patients

Joshua Fitch, Senior Editor
December 9th 2024
Article

Respondents reported decreased diarrhea severity, improved patient quality of life, and decreased treatment discontinuation among patients with Rett syndrome treated with trofinetide.

Weekly review: COVID-19 roundtable discussion, migraine prevention, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: COVID-19 roundtable, upadacitinib data for AD, and more

Joshua Fitch, Senior Editor
December 9th 2024
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

© 2024 MJH Life Sciences

All rights reserved.